loading...

ABC Dementia Scale (ABC-DS)

ABC Dementia Scale Study Group

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Published in 2018

Authors

ABC Dementia Scale Study Group

Copyright
ABC Dementia Scale © Translational Research Center for Medical Innovation, 2017
Objective
To assess Alzheimer’s Disease (AD) severity
Therapeutic area
  • Nervous System Diseases
  • Mental Disorders
Therapeutic indication

Alzheimer Disease

Type of Clinical Outcome Assessment (COA)
  • clinro ClinRO
Carer's administered
Original language(s)
  • Japanese for Japan
The original Japanese version shall be obtained directly from Dr Takashi Kikuchi. Please contact abc_scale@tri-kobe.org.
Bibliographic reference(s) of the original questionnaire

Kikuchi T, Mori T, Wada-Isoe J, Umeda-Kameyama Y, Kagimura T,  Kojima S, Akishita M, Nakamura Y.  A Novel Dementia Scale for Alzheimer’s Disease . J Alzheimers Dis Parkinsonism. 2018; 8(2):1-7.  (Full text article)

Mori T, Kikuchi T, Umeda-Kameyama Y, Wada-Isoe K, Kojima S, Kagimura T, Kudoh C, Uchikado H, Ueki A, Yamashita M, Watabe T, Nishimura C, Tsuno N, Ueda T,Akishita M, Nakamura Y; ABC Dementia Scale Study Group. ABC Dementia Scale: A Quick Assessment Tool for Determining Alzheimer's Disease Severity. Dement Geriatr Cogn Dis Extra. 2018 Mar 14;8(1):85-97. (Full text article)


Contact and conditions of use

Authors

ABC Dementia Scale Study Group

Corresponding author:
Takashi Kikuchi
Foundation for Biomedical Research and Innovation
Email: abc_scale@tri-kobe.org

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

If you do not receive specific funding for your study, you may download the questionnaire directly:

  1. Log in or Register for free
  2. Click the 'Online distribution' tab in the left menu bar and follow the instructions

Tutorials are available on our FAQs.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. Click the link below for the user agreement template.
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

If the users of ABC-DS want to use the patented evaluation algorithm or the Three Dimensional distance (TDD) in a commercial clinical trial or a funded academic research, another fee will be charged.For details, please contact to Dr. Takashi Kikuchi.

Access fees

ROYALTY FEES* Commercial users Cost per study NO RF before March 30, 2020
Cost per language NO RF before March 30, 2020
Funded academic research Cost per study NO RF before March 30, 2020
Cost per language NO RF before March 30, 2020
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES* Commercial users Cost per study Free
Cost per language 500 €
Funded academic research Cost per study Free
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Conditions to translate

Please refer to the "Languages" tab

Author Website(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • Japanese for Japan
The original Japanese version shall be obtained directly from Dr Takashi Kikuchi. Please contact abc_scale@tri-kobe.org.

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

ABC-DS

Chinese for China
English for the USA
French for France
Korean for Korea

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

More information on translations

For information on, or permission to use the translations, please contact Mapi Research Trust.

Online distribution

My study is not funded

  • I am a non-commercial user
  • I do not receive specific funding for my study
  • I intend to use the questionnaire in individual clinical practice or research study
Login SIGN up free

My study is funded

If your study is funded, or if you haven't found your translation in the Languages menu, please submit your request online.

Our team will get back to you as soon as possible.

Member Access

Subscribe to PROQOLID to access to full informations

And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!

A question? Contact us